A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2006
10/12/2006	US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/12/2006	US20060229319 For treatment of allergies; antihistamines
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229290 Staurosporine derivatives for hypereosinophilic syndrome
10/12/2006	US20060229242 Composition comprising a pulmonary surfactant and a pde2 inhibitor
10/12/2006	US20060229241 Hypoxia induced mitogenic factor
10/12/2006	US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
10/12/2006	US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006	US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006	US20060228306 Combination antihistamine and steroid medication
10/12/2006	US20060228305 Pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
10/12/2006	DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms
10/12/2006	DE10064219B4 Neue Fentanyl und/oder dessen Derivate enthaltende enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or derivatives thereof containing containing pharmaceutical composition for nasal administration
10/12/2006	CA2648522A1 Substituted azetidinones
10/12/2006	CA2604016A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives
10/12/2006	CA2603347A1 Oil-in-water emulsions of lignans that exhibit improved absorption rate
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1709995A1 Asthma/allergy therapy using nigella sativa
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709961A1 Use of Docosahexaenoic Acid and/or Arachidonic Acid for preventing or treating respiratory infections in infants
10/11/2006	EP1709036A1 Thiazole derivatives as a2b antagonists
10/11/2006	EP1708999A1 Bronchorelaxing compounds
10/11/2006	EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006	EP1708753A1 Use of goat serum for veterinary treatment
10/11/2006	EP1708717A2 Treatment of allergic rhinitis and asthma
10/11/2006	EP1708715A1 Use of substituted pteridines for the treatment of diseases of the respiratory tract
10/11/2006	EP1708714A1 Use of substituted pyrimido pyrimido 5,4-d¨pyrimidines in the treatment of diseases of the respiratory tract
10/11/2006	EP1708708A1 Montelukast free acid polymorphs
10/11/2006	EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists
10/11/2006	EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006	EP1471896B1 Formulations for inhalation
10/11/2006	EP1363903B1 Indole derivatives and their use as gnrh antagonists
10/11/2006	EP1303258B1 Novel aerosol formulation containing a polar fluorinated molecule
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP0804479B1 Method of treating diabetes mellitus using kgf
10/11/2006	CN1845926A Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
10/11/2006	CN1845911A Condensed ring compound and use thereof
10/11/2006	CN1844118A Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor
10/11/2006	CN1843505A Compound Doxycycline lysozyme enteral capsule
10/11/2006	CN1843499A Traditional Chinese medicine formulation for treating bronchitis and tonsillitis
10/11/2006	CN1843487A Gen-seng lung-protecting formulation and its novel preparation method
10/11/2006	CN1843458A Chronic pharyngolaryngitis effervescence tablet and preparation method and its quality control method
10/11/2006	CN1843452A Plaster for relieving asthma and stopping cough and its preparation method
10/11/2006	CN1843440A Traditional Chinese medicine formulation and its novel preparation method
10/11/2006	CN1843433A Chinese medicine for treating rhinitis
10/11/2006	CN1843402A Drop pill for pharynx health and its preparation method
10/11/2006	CN1843395A Antibacterial and inflammatory-diminishing tincture containing bee glue
10/11/2006	CN1843372A Pharmaceutical compositions separately constituted by ambroxol and two other antibacterials
10/11/2006	CN1843351A Bilobalide B powder injection and its preparing method
10/11/2006	CN1843344A Method for preventing or treating respiratory infections in infants
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity
10/11/2006	CN1279040C Tryasolyl tropane derivatives for therapy
10/11/2006	CN1279029C Pyrazolobenzodiazepines as CDK2 inhibitors
10/11/2006	CN1279023C Indole-3-sulphur derivatives
10/11/2006	CN1278726C Medicine composition capable of benefiting vital energy, activating pulse, nourishing yin and promoting the secretion of the body fluid and preparation method thereof
10/11/2006	CN1278674C Orally disintegrating tablet of throat clearing medicine and its preparation process
10/11/2006	CN1278673C Spray agent of dried powder in use for diminishing inflammation of mucous membrane and preparation method
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/10/2006	US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/10/2006	US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens
10/10/2006	US7119107 Pyridone derivatives
10/10/2006	US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist
10/10/2006	US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7118888 Gene expression vaccine
10/10/2006	US7118856 Enzyme catalyst; polypeptides; crystal structure
10/10/2006	US7118770 Plant extracts formed via steam distillation of essential oils
10/10/2006	US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA
10/10/2006	CA2290521C Medicinal aerosol products
10/07/2006	CA2516873A1 Method for preventing or treating respiratory infections in infants
10/05/2006	WO2006105219A2 T cell therapy for the treatment of cachexia and chronic diseases
10/05/2006	WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006	WO2006104190A1 Par-2 agonist
10/05/2006	WO2006103401A2 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
10/05/2006	WO2006057884A3 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES
10/05/2006	WO2005080338A8 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins
10/05/2006	WO2005042028A3 Il-13 conjugated to an immunogen and uses thereof
10/05/2006	US20060223836 New phenylalanine derivatives
10/05/2006	US20060223819 Quinoline Derivatives as NK-3 Antagonists
10/05/2006	US20060222646 Anti-TNFalpha antibodies in therapy of asthma
10/05/2006	DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals
10/05/2006	CA2603433A1 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
10/05/2006	CA2602075A1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
10/04/2006	EP1707566A1 Deazapurines and uses thereof
10/04/2006	EP1707216A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
10/04/2006	EP1707205A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
10/04/2006	EP1706389A1 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses
10/04/2006	EP1706119A1 Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors
10/04/2006	EP1706118A1 New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
10/04/2006	EP1706114A1 Chemical inhibitors of soluble adenylyl cyclase (sac)
10/04/2006	EP1706099A1 A medical product comprising tiotropium in a moisture-proof container
10/04/2006	EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide

1 ... 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 ... 878